Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.8500
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST

Cell Source Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
2.132.62.182.72.641.17
Research & Development
1.91.5821.3212.63
Operating Expenses
4.034.184.184.023.643.81
Operating Income
-4.03-4.18-4.18-4.02-3.64-3.81
Interest Expense
-1.01-1.05-0.99-1.36-0.94-0.31
Other Non Operating Income (Expenses)
-0.070.01--0.02-0.14
EBT Excluding Unusual Items
-5.11-5.22-5.17-5.38-4.56-4.25
Legal Settlements
-0.14-0.14----
Other Unusual Items
0.020.04--0.09-0-0.23
Pretax Income
-5.23-5.32-5.17-5.47-4.56-4.48
Net Income
-5.23-5.32-5.17-5.47-4.56-4.48
Preferred Dividends & Other Adjustments
1.341.231.160.970.880.74
Net Income to Common
-6.57-6.55-6.33-6.45-5.44-5.22
Shares Outstanding (Basic)
413835332928
Shares Outstanding (Diluted)
413835332928
Shares Change (YoY)
10.08%8.47%5.19%13.81%2.72%2.83%
EPS (Basic)
-0.16-0.17-0.18-0.19-0.19-0.18
EPS (Diluted)
-0.16-0.17-0.18-0.19-0.19-0.18
Free Cash Flow
-2.66-2.35-3.14-3.38-2.77-2.59
Free Cash Flow Per Share
-0.07-0.06-0.09-0.10-0.10-0.09
EBIT
-4.03-4.18-4.18-4.02-3.64-3.81
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.